In honor of Women’s History Month, this special-edition issue is completely written and designed by women who are “Más Que Modelos”—More than Models CHICAGO, March 07, 2024 (Korea Bizwire) – Known for their hopping hydraulics, custom upholstery and intricate paint jobs, lowrider cars are symbols of empowerment, freedom and a celebration of culture. As a [...]
Solidifying Its Position as a Leading Medical Tourism Hub KUALA LUMPUR, Malaysia, March 07, 2024 (Korea Bizwire) – In a monumental achievement for the nation, two Malaysian hospitals have been recognised in the highly respected Newsweek & Statista’s World’s Best Hospitals 2024. This marks Malaysia’s first-ever inclusion, signifying a pivotal moment in its journey towards [...]
WALTHAM, Mass., March 06, 2024 (Korea Bizwire) – Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of inflammation and immunology-directed therapies, today announced the appointment of Patricia Allen to its Board of Directors, on which she also will serve as Chairperson of the Audit Committee. Ms. Allen [...]
TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 06, 2024 (Korea Bizwire) – Cellebrite DI Ltd. (Nasdaq: CLBT), a leader in premier Digital Investigative solutions for the public and private sectors, today announced that Haim Shani has retired as a director of the Company, effective immediately. Mr. Shani had been a distinguished member of the [...]
March 6, 2024 (Korea Bizwire) – Company’s innovative products and solutions improved the lives of 1.9 billion people in 2023 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has been included in the 2024 Clarivate Top 100 Global Innovator™ list. Philips’ global R&D programs and collaborations aim to deliver personal [...]
Wyost® (denosumab-bddz) and Jubbonti® (denosumab-bddz) interchangeable with and approved by FDA for all indications of reference medicines Xgeva ®* (denosumab) and Prolia®* (denosumab) FDA approval based on robust clinical studies and totality of evidence, which show no clinically meaningful differences from reference medicines Basel, March 5, 2024 (Korea Bizwire) – Sandoz, the global leader in generic and biosimilar medicines, [...]
Available within IIBA’s online collection of content, knowledge, and tools, the new AI assistant is a member-only feature that provides AI-generated responses aligned with globally recognized standards in business analysis TORONTO, March 05, 2024 (Korea Bizwire) – The International Institute of Business Analysis (IIBA) is pleased to announce the beta launch of an AI assistant in its [...]
March 5, 2023 (Korea Bizwire) – Financial Times and Statista have acknowledged Pomilio Blumm as one of the fastest-growing companies in Europe. The latest edition of the “FT 1000 Europe’s Fastest Growing Companies” has crowned Pomilio Blumm, an Italian communications agency, as the leader for revenue in the “Advertising & Marketing” category across 35 countries, [...]
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE Mathai Mammen and Michael Rechsteiner nominated to stand for election to Sandoz Board of Directors at upcoming Annual General Meeting Remco Steenbergen appointed as Sandoz CFO and member of Executive Committee as of July 1, 2024, and consequently not standing for [...]
Breaking New Ground in Cannabinoid Research: Brains Bioceutical Corp’s Solid THC Paves the Way for Revolutionary Drug Development for the pharmaceutical industry. Vancouver, Canada & London, United Kingdom, March 05, 2024 (Korea Bizwire) — Brains Bioceutical Corp (“Brains Bio” or the “Company”), Brains Bio, a pioneer in the cannabinoid-based pharmaceutical industry, is proud to announce [...]